IBEX Ltd CEO Robert Thomas Dechant sells 5,000 shares

The $50.0062 weighted average reflected multiple trades executed at prices from $50.00 to $50.14.

Available on EDGAR 11/10/2026 - 05:13 PM EST Accepted by SEC EDGAR 11/10/2026 - 05:13 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

IBEX Ltd Chief Executive Officer Robert Thomas Dechant sold 5,000 common shares on November 9, 2026, at a weighted average price of $50.0062 per share. The sale was made under his Rule 10b5-1 Plan dated November 18, 2025. After the sale, he directly held 297,448 common shares.

Insider Trade Summary 10b5-1

Net Seller: 5,000 shares

Net Sell 1 txn

Insider Dechant Robert Thomas

Role Chief Executive Officer

Sold 5,000 shs ($250K)

Share of Position Sold 1.7%

Type	Security	Shares	Price	Value
Sale	Common Shares F1, F2	5,000	$50.0062	$250K

Holdings After Transaction: Common Shares — 297,448 shares (Direct)

Holdings Before and After: Common Shares, 302,448 to 297,448 shares (Direct)

Footnotes (2)

1. F1. Sales made pursuant to the Reporting Person's 10b5-1 Plan dated November 18, 2025.
2. F2. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.14; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Common shares sold: 5,000 shares Weighted average sales price: $50.0062 per share Trade-price range: $50.00 to $50.14 per share +1 more

4 metrics

Common shares sold 5,000 shares Transaction dated November 9, 2026

Weighted average sales price $50.0062 per share Transaction dated November 9, 2026

Trade-price range $50.00 to $50.14 per share Multiple trades for the reported sale

Direct common shares following transaction 297,448 shares After the November 9, 2026 sale

Key Terms

10b5-1 Plan, weighted average sales price

2 terms

10b5-1 Plan regulatory

"Sales made pursuant to the Reporting Person's 10b5-1 Plan"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

weighted average sales price financial

"the price reported above reflects the weighted average sales price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IBEX shares did CEO Robert Thomas Dechant sell, and at what price?

Robert Thomas Dechant sold 5,000 common shares on November 9, 2026, at a weighted average price of $50.0062 per share. The sale was made under a Rule 10b5-1 Plan dated November 18, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dechant Robert Thomas

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/09/2026		S(1)		5,000	D	$50.0062(2)	297,448	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sales made pursuant to the Reporting Person's 10b5-1 Plan dated November 18, 2025.

2. This transaction was executed in multiple trades at prices ranging from $50.00 to $50.14; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	11/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)